CNTB
Connect Biopharma Holdings
CNTB
CNTB
29 hedge funds and large institutions have $13M invested in Connect Biopharma Holdings in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
76% less capital invested
Capital invested by funds: $53.4M → $13M (-$40.4M)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$959K | |
| 2 | +$754K | |
| 3 | +$603K | |
| 4 |
Citigroup
New York
|
+$551K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$368K |
Top Sellers
| 1 | -$3.36M | |
| 2 | -$1.35M | |
| 3 | -$1.3M | |
| 4 |
BlackRock
New York
|
-$1.18M |
| 5 |
Barclays
London,
United Kingdom
|
-$947K |